Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
₹ 256000 / 2000 Shares Shares
Minimum Investment
Curis Lifesciences Limited IPO
Issues Price
₹120-128 per equity share
Curis Lifesciences Limited IPO
Open Date
07 Nov 2025
Close Date
11 Nov 2025
Lot Size
1000
Min. Investment
₹ 256000
Issue Price
₹120-128
Listing Date
14 Nov 2025
Issues Size
21,50,000 shares(aggregating up to ₹27.52 crore)
Face Value
₹10 Per Equity Share
Total Shares Offered
2000 Shares
Offered To Public
2000 Shares
Curis Lifesciences Limited IPO
Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.
Founded In
2020
Managing Director
Dharmesh Dasharathbhai Patel
Parent Organization
Curis Lifesciences Limited IPO
Application for Curis Lifesciences Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹120-128 | ₹2,56,000 |
| Individual(max) | ₹120-128 | ₹2,56,000 |
| SHNI(min) | ₹120-128 | ₹3,84,000 |
| SHNI(max) | ₹120-128 | ₹8,96,000 |
| BHNI(min) | ₹120-128 | ₹10,24,000 |
Apply for all eligible candidates, Curis Lifesciences Limited IPO.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
I've explored several NFOs through KSquare, and their consistent communication builds trust. It’s great having expert updates every step of the way.
KSquare presents each new fund launch with such clarity. Their tools gave me better understanding of sectors and fund outlooks before investing.
I appreciated how KSquare simplified the NPS jargon. Everything was laid out clearly with ongoing support.
KSquare’s loan facility saved me during a financial crunch. I didn’t need to touch my investments—very helpful!
KSquare delivers exceptional clarity in their NFO briefings. Their platform made participating easy, and I felt informed throughout the whole process.
KSquare provides a transparent and smooth mutual fund experience. Their portfolio tools are user-friendly, and I love how effortless it feels to invest monthly.
I used to avoid NFOs due to uncertainty. KSquare’s clear data and investor tools changed my mind. Now, I feel fully informed and prepared.
KSquare gave me confidence to grow wealth in India from abroad. The onboarding was smooth, and they guided me at every step.
KSquare gave me clarity in my mutual fund journey. I now know where my money goes and how it grows. Their dashboard is excellent.
The automatic deductions and growth charts at KSquare keep me informed and on track. It’s great for anyone serious about long-term financial goals.
FAQ's
Frequenlty Asked Question
Are SIP investments safe?
While SIPs are subject to market risks, long-term investing and diversification help reduce risk and improve returns.
How does KSquare help in retirement planning?
KSquare builds long-term SIP strategies to create a secure retirement corpus based on future lifestyle, needs, and inflation.
Can I open multiple NPS accounts?
No, you’re allowed only one NPS Tier I account, which is linked to your Permanent Retirement Account Number (PRAN).
How is SIP different from recurring deposits?
Unlike fixed-interest recurring deposits, SIP returns are market-linked and offer higher growth potential with some risk.
Can I nominate someone in India for my investments?
Yes, NRIs can nominate any Indian resident for their mutual fund holdings and other financial assets via KSquare.
What are the benefits of investing in SIP through KSquare?
KSquare offers easy tracking, expert advice, and a simple setup to help you invest regularly and meet financial goals.
Are there any charges for managing NPS?
Yes, nominal charges apply for account maintenance and fund management, but they are among the lowest in the industry.
When do NFO units get credited to my account?
Units are credited within a few days after the NFO closes and the scheme is processed by the fund house.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.